Articles by Keyword for

  Estrogen blockers (Tamoxifen) are often used to treat breast cancer with estrogen sensitive tumors in premenopausal women. Yet there are problems such as an increased rate of uterine cancer and clotting problems. In postmenopausal women, most estrogen does not come from the ovary; it comes from estrogen production in fat tissues and from the conversion...

  Getting less than 6 hours a night of sleep is a risk factor in postmenopausal women with stage 1 or 2, estrogen positive, node negative breast cancer using the Oncotype DX tumor test. It measures the risk of tumor recurrence based on the expression of 21 oncogenes. Lack of sleep causes inflammation in the body that increases the risk for obesity,...

Zometa, a bisphosphonate drug used to prevent bone metastases in women with breast cancer, was serendipitously found to reduce metastases and extend life by 37%. This translates to 4-5 out of 100 being alive 7 years later. An IV infusion was given every six months for 3 years. Cost is between $1500 and $2500 per injection. All patients were early-stage and had...